when taking tirzepatide Dosage Guide and Chart for Weight Loss To keep pounds off, patients

It is important to note that individual responses to medication can vary

Most common adverse events at all doses: Nausea (15-30%, dose-related) Vomiting (5-15%) Decreased appetite (~20%) Constipation (5-12%) Cagrilintide-specific notes: A 2025 Bayesian network meta-analysis of incretin-based therapies reported cagrilintide had one of the lowest GI odds ratios across the studied compound class

Aldridge RE, Chan T, van Dalen CJ, Senthilmohan R, Winn M, et al: Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics

GLP-1 RAs can cause feelings of early fullness, as well as nausea, vomiting, and diarrhea

It helps neutralize free radicals and supports the bodys natural ability to eliminate toxins